The research group of Dr. Mojgan Karimabad found increased serum levels of CXCL1 and CXCL12, chemokines with pro-angiogenic properties [246,247,248], in neonates from GDM mothers, whereas antiangiogenic chemokines CXCL9 and CXCL10 were downregulated, compared to neonates from healthy mothers without GDM [249]. Here, CXCL1 is linked to gestational diabetes.